Antitumor active monofunctional platinum(II) complexes: Synthesis, structural characterization and reactivity towards biomolecules

Inorganic Chemistry Communications

Volumn 9, Issue 7, 2006, Pages 722-726

  Gao, Xinliu ^a   Wang, Xiaoyong ^b   Ding, Jian ^c   Lin, Liping ^c   Li, Yizhi ^a   Guo, Zijian ^a  

^a NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Antitumor agents; Drug design; Medicinal chemistry; Platinum; Structure activity relationship

Indexed keywords

EID: 33744989436     PISSN: 13877003     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.inoche.2006.04.011     Document Type: Article

References (29)

1. Galanski M., Jakupec M.A., and Keppler B.K. Curr. Med. Chem. 12 (2005) 2075-2094
2. Wong E., and Giandomenico C.M. Chem. Rev. 99 (1999) 2451-2466
3. Cleare M.J., and Hoeschele J.D. Bioinorg. Chem. 2 (1973) 187-210
4. Hartmann J.T., and Lipp H.P. Expert Opin. Pharmacother. 4 (2003) 889-901
5. Mellish K.J., Barnard C.F., Murrer B.A., and Kelland L.R. Int. J. Cancer 62 (1995) 717-723
6. Farrell N. Met. Ions Biol. Syst. 32 (1996) 603-639
7. Farrell N., Qu Y., and Roberts J.D. Top. Biol. Inorg. Chem vol. 1 (1999), Springer, Berlin pp. 99-115
8. Hambley T.W. Coordin. Chem. Rev. 166 (1997) 181-223
9. Hollis L.S., Amundsen A.R., and Stern E.W. J. Med. Chem. 32 (1989) 128-136
10. Farrell N. Comments Inorg. Chem. 16 (1995) 373-389
11. Brabec V., Vrána O., Nováková O., Kleinwächter V., Intini F.P., Coluccia M., and Natile G. Nucleic Acids Res. 24 (1996) 336-341
12. Zhang J.Y., Wang X.Y., Tu C., Lin J., Ding J., Lin L.P., Wang Z.M., He C., Yan C.H., You X.Z., and Guo Z.J. J. Med. Chem. 46 (2003) 3502-3507
13. 3) ppm.
14. Price J.H., Williamson A.N., Schramm R.F., and Wayland B.B. Inorg. Chem. 11 (1972) 1280-1284
15. 3) ppm.
16. -5 M, respectively. UV-Vis spectra were recorded at 37 °C every other 10 min during 3 h as soon as CT-DNA was added (molar ratio = 1:1).
17. LePecq J.B., and Paoletti C. J. Mol. Biol. 27 (1967) 87-106
18. Wei H.Y., Wang X.Y., and Guo Z.J. Platinum-sulfur interactions and new platinum-based drug design. In: Pérez J.M., Fuertes M.A., and Alonso C. (Eds). Metal Compounds in Cancer Chemotherapy (2005), Research Signpost, Kerala, India 241-267
19. Holford J., Sharp S.Y., Murrer B.A., Abrams M., and Kelland L.R. Br. J. Cancer 77 (1998) 366-373
20. Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., and Boyd M.R. Cancer Res. 48 (1988) 589-601
21. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., and Boyd M.R. J. Natl. Cancer Inst. 82 (1990) 1107-1112
22. Natile G., and Coluccia M. Coordin. Chem. Rev. 216 (2001) 383-410
23. Bauer C., Peleg-Shulman T., Gibson D., and Wang A.H.J. Eur. J. Biochem. 256 (1998) 253-260
24. Peleg-Shulman T., Katzhendler J., and Gibson D. J. Inorg. Biochem. 81 (2000) 313-323
25. Kopf-Maier P., and Muhlhausen S.K. Chem. Biol. Interact. 82 (1992) 295-316
26. Boekelheide K., Arcila M.E., and Eveleth J. Toxicol. Appl. Pharmacol. 116 (1992) 146-151
27. Lacour S., Hammann A., Grazide S., Lagadic-Gossmann D., Athias A., Laurent G., Gambert P., Solary E., and Dimanche-Boitrel M.T. Cancer Res. 64 (2004) 3593-3598
28. Szachowicz-Petelska B., Figaszewski Z., and Lewandowski W. Int. J. Pharm. 222 (2001) 169-182
29. Burger K.N., Staffhorst R.W., and de Kruijff B. Biochim. Biophys. Acta 1419 (1999) 43-54